Zynex, Inc. (ZYXI)
After hours:
| Previous close | 10.97 |
| Open | 11.06 |
| Bid | 11.73 x 500 |
| Ask | 11.78 x 700 |
| Day's range | 11.06 - 12.17 |
| 52-week range | 6.88 - 13.77 |
| Volume | |
| Avg. volume | 193,036 |
| Market cap | 375.813M |
| Beta (5Y monthly) | 0.45 |
| PE ratio (TTM) | 43.59 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 05 Jan 2022 |
| 1y target est | N/A |
- PR Newswire
Zynex Reports First Quarter 2024 Financial Results
Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today reported its financial and operational results for the first quarter ended March 31, 2024.
- PR Newswire
Zynex Sets First Quarter 2024 Earnings Call
Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, will hold a conference call on Tuesday, April 30, 2024 at 4:15 PM Eastern Time to discuss its financial results for the first quarter ended March 31, 2024. Financial results will be issued in a press release prior to the call.
- PR Newswire
Zynex Earns Prestigious 2024 Top Workplaces USA Employer Recognition Award
Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced it is a recipient of the prestigious 2024 Top Workplaces USA award, featured in USA TODAY. This achievement underscores the organization's dedication to fostering a people-first workplace culture and prioritizing the employee experience.
